Status:

COMPLETED

Weight Management in Nonalcoholic Steatohepatitis

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Fatty Liver

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases. The cause of NASH is not completely understood and currently there is no effective treatment for this disease. An ...

Detailed Description

Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases. The cause of NASH is not completely understood and currently there is no effective treatment for this disease. An ...

Eligibility Criteria

Inclusion

  • Evidence of chronic steatohepatitis on liver biopsy.
  • Elevated alanine or aspartate aminotransferase values (ALT \> 41 or AST \> 34) within 3 months of enrollment
  • Absence of another form of liver disease
  • Body mass index between 25-50 kg/m2.
  • At least 18 years of age
  • Absence of significant alcohol consumption (more than one standard drink per day).
  • Able to walk 2 blocks or a quarter of a mile without stopping
  • Willing to complete a two-week run-in period with successful completion of self-monitoring records.

Exclusion

  • \< 18 years of age
  • Significant alcohol consumption (\> 1 standard drink per day)
  • Contraindications to obtaining a liver biopsy
  • Unable to walk 2 blocks or a quarter of a mile without stopping
  • Currently pregnant or pregnant in the previous six months
  • Currently engaged in an active weight-loss program or taking weight-loss medication
  • Report conditions that, in the judgment of the investigators, render potential participants unlikely to follow the protocol for 12 months, including illness likely to be terminal within 2 years, plans to move, substance abuse, or other significant psychiatric problems

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2007

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00266019

Start Date

January 1 2005

End Date

December 1 2007

Last Update

January 13 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rhode Island Hospital

Providence, Rhode Island, United States, 02903

Weight Management in Nonalcoholic Steatohepatitis | DecenTrialz